Neil I. Goldstein

5.4k citations

64 papers · 4.3k indexed · 2 hit papers · h-index 27

Molecular Biology top 5%
Oncology top 1%
Immunology top 5%
Genetics top 2%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Patricia Rockwell Paul B. Fisher Marie Prewett Zao-zhong Su John Mendelsohn Hongping Jiang Jiao Jiao Lin Janusz Rak
Topics: Monoclonal and Polyclonal Antibodies Research (16 papers)Glycosylation and Glycoproteins Research (9 papers)Virus-based gene therapy research (7 papers)
Cited by: Oncology Immunology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Medicine
Partner nations: United States Czechia Netherlands

In The Last Decade

Neil I. Goldstein

63 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

1997 679 citations Janusz Rak, Mien‐Chie Hung et al. PubMed profile →
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

1995 657 citations Neil I. Goldstein, Patricia Rockwell et al. PubMed profile →

Peers

Countries citing papers authored by Neil I. Goldstein

Since Specialization

Citations

This map shows the geographic impact of Neil I. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil I. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil I. Goldstein more than expected).

Fields of papers citing papers by Neil I. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil I. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil I. Goldstein. The network helps show where Neil I. Goldstein may publish in the future.

Co-authorship network of co-authors of Neil I. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Neil I. Goldstein. A scholar is included among the top collaborators of Neil I. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil I. Goldstein. Neil I. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Directed protein engineering identifies a human TIM-4 blocking antibody that enhances anti-tumor response to checkpoint inhibition in murine colon carcinoma 2024 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Neil I. Goldstein	0
2	The Use of Phage Display Peptide Libraries for Basic and Translational Research 2007 ·Humana Press eBooks ·R E Brissette,Neil I. Goldstein	26
3	Surface-Epitope Masking (SEM) 2007 ·Humana Press eBooks ·Neil I. Goldstein,Paul B. Fisher	2
4	Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2. 2003 ·Proteome Science ·Ku-chuan Hsiao,R E Brissette,Pinger Wang,Paul W. Fletcher,Vanessa Rodríguez‐Fanjul,Michael Lennick,Arthur J. Blume,Neil I. Goldstein	22
5	Peptides Identify the Critical Hotspots Involved in the Biological Activation of the Insulin Receptor 2002 ·Journal of Biological Chemistry ·Renuka Pillutla,Ku-chuan Hsiao,James R. Beasley,Jakob Brandt,Søren Østergaard,Per Hansen,Jane C. Spetzler,Gillian M. Danielsen,Asser S. Andersen,R E Brissette,Michael Lennick,Paul W. Fletcher,Arthur J. Blume,Lauge Schäffer,Neil I. Goldstein	74
6	Target validation and drug discovery using genomic and protein–protein interaction technologies 2002 ·Expert Opinion on Therapeutic Targets ·Renuka Pillutla,Paul B. Fisher,Arthur J. Blume,Neil I. Goldstein	16
7	Mda-7, A Novel Melanoma Differentiation Associated Gene with Promise for Cancer Gene Therapy 2002 ·Advances in experimental medicine and biology ·Malavi T. Madireddi,Zao-zhong Su,(unknown),Neil I. Goldstein,Paul B. Fisher	71
8	A surrogate-based approach for post-genomic partner identification 2001 ·BMC Biotechnology ·Renuka Pillutla,Ku-chuan Hsiao,R E Brissette,Paul S. Eder,Tony Giordano,Paul W. Fletcher,Michael Lennick,Arthur J. Blume,Neil I. Goldstein	9
9	The use of peptides in Diogenesis: A novel approach to drug discovery and phenomics 2000 ·Biopolymers ·Arthur J. Blume,James R. Beasley,Neil I. Goldstein	15
10	Translational infidelity and human cancer: role of the PTI-1 oncogene 1999 ·The International Journal of Biochemistry & Cell Biology ·Rahul V. Gopalkrishnan,Zao-zhong Su,Neil I. Goldstein,Paul B. Fisher	36
11	Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells 1999 ·Oncogene ·Fei Huang,(unknown),Hongping Jiang,Neil I. Goldstein,Paul B. Fisher	52
12	Differentiation induction subtraction hybridization (DISH): a strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation 1999 ·Gene ·Fei Huang,(unknown),Hongping Jiang,Neil I. Goldstein,Paul B. Fisher	42
13	The cancer growth suppressor gene mda- 7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice 1998 ·Proceedings of the National Academy of Sciences ·Zao-zhong Su,Malavi T. Madireddi,Jiao Jiao Lin,(unknown),Shinichi Kitada,John C. Reed,Neil I. Goldstein,Paul B. Fisher	221
14	Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.breakdown → 1997 ·PubMed ·(unknown),Janusz Rak,Mien‐Chie Hung,Patricia Rockwell,Neil I. Goldstein,B M Fendly,Robert S. Kerbel	679
15	Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes 1997 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Jennifer Harding,Charles Engbers,Mary S. Newman,Neil I. Goldstein,Samuel Zalipsky	154
16	Halting angiogenesis suppresses carcinoma cell invasion 1997 ·Nature Medicine ·Mihaela Skobe,Patricia Rockwell,Neil I. Goldstein,Silvia Vosseler,Norbert E. Fusenig	375
17	Isolation and Characterization of a Monoclonal Antibody Binding to the Extracellular Domain of the flk-2 Tyrosine Kinase Receptor 1995 ·Hybridoma ·(unknown),Patricia Rockwell,(unknown),Bronislaw Pytowski,Neil I. Goldstein	2
18	Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. 1995 ·PubMed ·Hongping Jiang,Jiao Jiao Lin,Zao-zhong Su,Neil I. Goldstein,Paul B. Fisher	414
19	Surface-Epitope Masking: a Strategy for the Development of Monoclonal Antibodies Specific for Molecules Expressed on the Cell Surface 1994 ·JNCI Journal of the National Cancer Institute ·R Shen,(unknown),Craig A. Olsson,Neil I. Goldstein,P B Fisher	13
20	The Use of a Novel Immune Complex to Isolate Neutralizing Antibodies to Basic Fibroblast Growth Factor 1993 ·Hybridoma ·(unknown),Neil I. Goldstein	2

About Neil I. Goldstein

Neil I. Goldstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology and Molecular Biology, having authored 64 papers that have together received 4.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (9 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Oncology (2.1k citations), Immunology (752 citations) and Cancer Research (499 citations). Neil I. Goldstein has collaborated with scholars based in United States, Czechia and Netherlands. Frequent co-authors include Patricia Rockwell, Paul B. Fisher, Marie Prewett, Zao-zhong Su, John Mendelsohn, Hongping Jiang, Jiao Jiao Lin, Janusz Rak, B M Fendly and Robert S. Kerbel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact